EUVIMEDEUVIMED entdecken
Querschnittstudie

Assessment of preoperative gastric content with ultrasound in patients taking GLP-1 receptor agonists: an observational, multicenter, cross-sectional study

Oliver Panzer, Kanupriya K Kumar, Maya Tailor, Juliet Rowe, Michael N Singleton, William Manson, Hari Kalagara, Nibras Bughrara, Anahita Dabo-Trubelja, Marissa Weber, Eric Heinz, Stephen C Haskins und 14 weitere

Regional Anesthesia & Pain Medicine · 03.11.2026 · rapm-2026-108205

DOI: 10.1136/rapm-2026-108205 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Regional Anesthesia & Pain Medicine, online erschienen am 03.11.2026. Verfasst von Oliver Panzer und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology Critical Care & Pain Management, Hospital for Special Surgery, New York, New York, USA panzero@hss.edu. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Department of Anesthesiology, Critical Care & Pain Management, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) delay gastric emptying, and there have been incidents of pulmonary aspiration in patients who had followed standard preoperative fasting instructions while on GLP-1 RA therapy. As the use of GLP-1 RAs is rising, we aim to compare the preoperative gastric contents of elective surgical patients taking GLP-1 RAs with those not taking these medications. Secondary objectives were to study the association of the indication, dose, time since last dose, and hours of fasting with gastric content.

Methods

This cross-sectional, multi-center study included elective surgery patients taking weekly GLP-1 RA medications for all indications, and those not taking them. All patients underwent standardized bedside gastric ultrasound preoperatively. Statistical analysis included χ2 or Fisher’s exact testing, Mann-Whitney U testing, and a multivariable logistic regression of full stomach on GLP-1 RA users, controlling for potential confounders where data were available.

Results

A total of 354 patients were enrolled from August 29, 2023, to January 31, 2025. A total of 307 patients were analyzed, 151 in the GLP-1 RA group, and 156 in the non-GLP-1 RA group. The occurrence of a full stomach was not significantly different between groups (13.9% vs 10.3%, p=0.38). Adjusted regression analysis also did not show a significant difference in fullness between groups (p=0.61). Patients in the GLP-1 RA group had a significantly longer solid fasting time than the non-GLP-1 RA group (median (Q1, Q3): 18.5 (13.5, 25.45) vs 15.98 (14.27, 17.55) hours; p=0.002). Treatment indication, time since last dose, and duration were not significantly associated with the occurrence of full stomach.

Conclusions

This study found no difference in the occurrence of full stomach in elective surgical patients taking GLP-1 RAs compared with the non-GLP-1 RA group. A longer solid fasting time in the GLP-1 RA group may have contributed to this finding. Our results also indicate that longer fasting times alone may not eliminate the risk of full stomach in patients taking GLP-1 RAs. Trial registration number NCT06003985.

Schlagwörter

Stichwörter der Autor:innen

Diagnostic ImagingDrug-Related Side Effects and Adverse ReactionsUltrasonography

Autor:innen und Institutionen

  • Department of Anesthesiology Critical Care & Pain Management, Hospital for Special Surgery, New York, New York, USA panzero@hss.edu.
  • Department of Anesthesiology, Weill Cornell Medicine, New York, New York, USA.
  • Department of Anesthesiology Critical Care & Pain Management, Hospital for Special Surgery, New York, New York, USA.
  • Department of Anesthesiology, University of Virginia Health System, Charlottesville, Virginia, USA.
  • Department of Anesthesiology, Mayo Clinic, Rochester, New York, USA.
  • Anesthesiology and Crtical Care, Albany Medical Center, Albany, New York, USA.

Förderung

  • Department of Anesthesiology, Critical Care & Pain Management
  • National Center for Advancing Translational Sciences

Zitieren

APA

Panzer, O., Kumar, K. K., Tailor, M., Rowe, J., Singleton, M. N., Manson, W., Kalagara, H., Bughrara, N., Dabo-Trubelja, A., Weber, M., Heinz, E., Haskins, S. C., Qiao, W., Long, W., Sheetz, M., Illescas, A., Bernstein, K., Maramba, M., Sheikh, M., …, & Perlas, A. (2026). Assessment of preoperative gastric content with ultrasound in patients taking GLP-1 receptor agonists: an observational, multicenter, cross-sectional study. Regional Anesthesia & Pain Medicine, rapm-2026-108205. https://doi.org/10.1136/rapm-2026-108205

Vancouver

Panzer O, Kumar KK, Tailor M, Rowe J, Singleton MN, Manson W, et al. Assessment of preoperative gastric content with ultrasound in patients taking GLP-1 receptor agonists: an observational, multicenter, cross-sectional study. Regional Anesthesia & Pain Medicine. 2026:rapm-2026-108205. doi:10.1136/rapm-2026-108205

BibTeX
@article{Panzer2026,
  author = {Panzer, Oliver and Kumar, Kanupriya K and Tailor, Maya and Rowe, Juliet and Singleton, Michael N and Manson, William and Kalagara, Hari and Bughrara, Nibras and Dabo-Trubelja, Anahita and Weber, Marissa and Heinz, Eric and Haskins, Stephen C and Qiao, William and Long, William and Sheetz, Miriam and Illescas, Alex and Bernstein, Kayla and Maramba, Mariel and Sheikh, Mahtab and Chowdhury, Jayanta and Carr, Sheila and Gee, Tatum and Shaykhinurov, Eduard and Lauzadis, Justas and Poeran, Jashvant and Perlas, Anahi},
  title = {Assessment of preoperative gastric content with ultrasound in patients taking GLP-1 receptor agonists: an observational, multicenter, cross-sectional study},
  journal = {Regional Anesthesia & Pain Medicine},
  year = {2026},
  pages = {rapm--2026--108205},
  doi = {10.1136/rapm-2026-108205}
}
Kostenlos starten →